Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study

References

1. 1.↵
   1. Wang HY,
   2. Li XL,
   3. Yan ZR, et al

   . Potential neurological symptoms of COVID-19. Ther Adv Neurol Disord 2020;13:175628642091783 doi:10.1177/1756286420917830 pmid:32284735

   CrossRefPubMed
2. 2.↵
   1. Mao L,
   2. Jin H,
   3. Wang M, et al

   . Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol 2020;77:683–90 doi:10.1001/jamaneurol.2020.1127 pmid:32275288

   CrossRefPubMed
3. 3.↵
   1. Zhou F,
   2. Yu T,
   3. Du R, et al

   . Clinical course and risk factors for mortality of adult inpatients with Covid-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054–62 doi:10.1016/S0140-6736(20)30566-3 pmid:32171076

   CrossRefPubMed
4. 4.↵
   1. Lu R,
   2. Zhao X,
   3. Li J, et al

   . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395:565–74 doi:10.1016/S0140-6736(20)30251-8 pmid:32007145

   CrossRefPubMed
5. 5.↵
   1. Mankad K,
   2. Perry MD,
   3. Mirsky DM, et al

   . COVID-19: a primer for neuroradiologists. Neuroradiology 2020;62:647–48 doi:10.1007/s00234-020-02437-5 pmid:32342126

   CrossRefPubMed
6. 6.↵
   1. Baig AM,
   2. Khaleeq A,
   3. Ali U, et al

   . Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci 2020;11:995–98 doi:10.1021/acschemneuro.0c00122 pmid:32167747

   CrossRefPubMed
7. 7.↵
   1. Ruan Q,
   2. Yang K,
   3. Wang W, et al

   . Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med 2020;46:846–48 doi:10.1007/s00134-020-05991-x pmid:32125452

   CrossRefPubMed
8. 8.↵
   1. Li YC,
   2. Bai WZ,
   3. Hashikawa T

   . The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol 2020;92:552–55 doi:10.1002/jmv.25728 pmid:32104915

   CrossRefPubMed
9. 9.↵
   1. Xu Z,
   2. Shi L,
   3. Wang Y, et al

   . Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020;8:420–22 doi:10.1016/S2213-2600(20)30076-X pmid:32085846

   CrossRefPubMed
10. 10.↵
    1. Oxley TJ,
    2. Mocco J,
    3. Majidi S, et al

    . Large-vessel stroke as a presenting feature of Covid-19 in the young. N Engl J Med 2020;382:e60 doi:10.1056/NEJMc2009787 pmid:32343504

    CrossRefPubMed
11. 11.↵
    1. Saposnik G,
    2. Barinagarrementeria F,
    3. Brown RD Jr., et al

    . American Heart Association Stroke Council and the Council on Epidemiology and Prevention, Diagnosis and management of cerebral venous sinus thrombosis. a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:1158–92 doi:10.1161/STR.0b013e31820a8364 pmid:21293023

    Abstract/FREE Full Text
12. 12.↵
    1. Lee SK,
    2. Mokin M,
    3. Hetts SW, et al

    . Society of NeuroInterventional Surgery. Current endovascular strategies for cerebral venous thrombosis: report of the SNIS Standards and Guidelines Committee. J Neurointerv Surg 2018;10:803–10 doi:10.1136/neurintsurg-2018-013973 pmid:29871990

    FREE Full Text
13. 13.↵
    1. Jamil S,
    2. Mark N,
    3. Carlos G, et al

    . Diagnosis and management of COVID-19 disease. Am J Respir Crit Care Med 2020;201:P19–20 doi:10.1164/rccm.2020C1 pmid:2223716

    CrossRefPubMed
14. 14.↵
    1. Kothari RU,
    2. Brott T,
    3. Broderick JP, et al

    . The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996;27:1304–05 doi:10.1161/01.str.27.8.1304 pmid:8711791

    Abstract/FREE Full Text
15. 15.↵
    1. Dahl Cruz F,
    2. Guevara Dalrymple N,
    3. López Hernández N

    . Cerebral venous thrombosis and SARS-CoV-2 infection [in Spanish]. Rev Neurol 2020;70:391 doi:10.33588/rn.7010.2020204 pmid:32390132

    CrossRefPubMed
16. 16.
    1. Hughes C,
    2. Nichols T,
    3. Pike M, et al

    . Cerebral venous sinus thrombosis as a presentation of COVID-19. Eur J Case Rep Intern Med 2020;7:001691doi:10.12890/2020_001691 pmid:32399457

    CrossRefPubMed
17. 17.
    1. Garaci F,
    2. Di Giuliano F,
    3. Picchi E, et al

    . Venous cerebral thrombosis in COVID-19 patient. J Neurol Sci 2020;414:116871 doi:10.1016/j.jns.2020.116871 pmid:32422428

    CrossRefPubMed
18. 18.
    1. Poillon G,
    2. Obadia M,
    3. Perrin M, et al

    . Cerebral venous thrombosis associated with Covid-19 infection: causality or coincidence? J Neuroradiol 2021;48:121–24 doi:10.1016/j.neurad.2020.05.003 pmid:32437707

    CrossRefPubMed
19. 19.
    1. Hemasian H,
    2. Ansari B

    . First case of Covid-19 presented with cerebral venous thrombosis: a rare and dreaded case. Rev Neurol (Paris) 2020;176:521–23 doi:10.1016/j.neurol.2020.04.013 pmid:32414532

    CrossRefPubMed
20. 20.
    1. Klein D,
    2. Libman R,
    3. Kirsch C, et al

    . Cerebral venous thrombosis: a typical presentation of COVID-19 in the young. J Stroke Cerebrovasc Dis 2020;29:104989 doi:10.1016/j.jstrokecerebrovasdis.2020.104989 pmid:32689590

    CrossRefPubMed
21. 21.
    1. Cavalcanti DD,
    2. Raz E,
    3. Shapiro M, et al

    . Cerebral venous thrombosis associated with COVID-19. AJNR Am J Neuroradiol 2020;41:1–7 doi:10.3174/ajnr.A6644] pmid:32554424

    FREE Full Text
22. 22.
    1. Li Y,
    2. Li M,
    3. Wang M, et al

    . Acute cerebrovascular disease following COVID-19: a single center retrospective, observational study. Stroke Vasc Neurol 2020;5:279–84 doi:10.1136/svn-2020-000431 pmid:32616524

    Abstract/FREE Full Text
23. 23.
    1. Baudar C,
    2. Duprez T,
    3. Kassab A, et al

    . COVID-19 as triggering co-factor for cortical cerebral venous thrombosis? J Neuroradiol 2021;48:65–67 doi:10.1016/j.neurad.2020.06.008 pmid:32603768

    CrossRefPubMed
24. 24.
    1. Bolaji P,
    2. Kukoyi B,
    3. Ahmad N, et al

    . Extensive cerebral venous sinus thrombosis: a potential complication in a patient with COVID-19 disease. BMJ Case Rep 2020;13:e236820 doi:10.1136/bcr-2020-236820 pmid:32784243

    CrossRefPubMed
25. 25.
    1. Chougar L,
    2. Mathon B,
    3. Weiss N, et al

    . Atypical deep cerebral vein thrombosis with hemorrhagic venous infarction in a patient positive for COVID-19. AJNR Am J Neuroradiol 2020;41:1377–79 doi:10.3174/ajnr.a6642 pmid:32554423

    Abstract/FREE Full Text
26. 26.
    1. Chow LC,
    2. Chew LP,
    3. Leong TS, et al

    . Thrombosis and bleeding as presentation of COVID-19 infection with polycythemia vera: a case report. SN Compr Clin Med 2020 Oct 4. [Epub ahead of print] doi:10.1007/s42399-020-00537-0 pmid:33043250

    CrossRefPubMed
27. 27.
    1. Haroon KH,
    2. Muhammad A,
    3. Hussain S, et al

    . COVID-19 related cerebrovascular thromboembolic complications in three young patients. Case Rep Neurol 2020;12:321–28 doi:10.1159/000511179 pmid:33173491

    CrossRefPubMed
28. 28.
    1. Hoelscher C,
    2. Sweid A,
    3. Ghosh R, et al

    . Cerebral deep venous thrombosis and COVID-19: case report. J Neurosurg 2020 Sep 4. [Epub ahead of print] doi:10.3171/2020.5.JNS201542 pmid:32886922

    CrossRefPubMed
29. 29.
    1. Kananeh MF,
    2. Thomas T,
    3. Sharma K, et al

    . Arterial and venous strokes in the setting of COVID-19. J Clin Neurosci 2020;79:60–66 doi:10.1016/j.jocn.2020.07.005 pmid:33070919

    CrossRefPubMed
30. 30.
    1. Keaney K,
    2. Mumtaz T

    . Cerebral venous thrombosis in patients with severe COVID-19 infection in intensive care. Br J Hosp Med (Lond) 2020;81:1–4 doi:10.12968/hmed.2020.0327 pmid:32990081

    CrossRefPubMed
31. 31.
    1. Koh JS,
    2. De Silva DA,
    3. Quek AM, et al

    . Neurology of COVID-19 in Singapore. J Neurol Sci 2020;418:117118 doi:10.1016/j.jns.2020.117118 pmid:32977228

    CrossRefPubMed
32. 32.
    1. Malentacchi M,
    2. Gned D,
    3. Angelino V, et al

    . Concomitant brain arterial and venous thrombosis in a COVID-19 patient. Eur J Neurol 2020;27:e38–39 doi:10.1111/ene.14380 pmid:32503080

    CrossRefPubMed
33. 33.
    1. Mowla A,
    2. Shakibajahromi B,
    3. Shahjouei S, et al

    . Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series. J Neurol Sci 2020;419:117183 doi:10.1016/j.jns.2020.117183 pmid:33075595

    CrossRefPubMed
34. 34.
    1. Rifino N,
    2. Censori B,
    3. Agazzi E, et al

    . Neurologic manifestations in 1760 COVID-19 patients admitted to Papa Giovanni XXIII Hospital, Bergamo, Italy. J Neurol 2020 Oct 7. [Epub ahead of print] doi:10.1007/s00415-020-10251-5 pmid:33026520

    CrossRefPubMed
35. 35.
    1. Rouyer O,
    2. Pierre-Paul IN,
    3. Balde A, et al

    . High prevalence of deep venous thrombosis in non-severe COVID-19 patients hospitalized for a neurovascular disease. Cerebrovasc Dis Extra 2020 Dec 7. [Epub ahead of print] doi:10.1159/000513295 pmid:33285543

    CrossRefPubMed
36. 36.
    1. Roy-Gash F,
    2. Marine DM,
    3. Jean-Michel D, et al

    . COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features. Crit Care 2020;24:419 doi:10.1186/s13054-020-03131-x pmid:32653019

    CrossRefPubMed
37. 37.
    1. Shahjouei S,
    2. Naderi S,
    3. Li J, et al

    . Risk of stroke in hospitalized SARS-CoV-2 infected patients: a multinational study. EBioMedicine 2020;59:10293 doi:10.1016/j.ebiom.2020.102939 pmid:32818804

    CrossRefPubMed
38. 38.
    1. Siegler JE,
    2. Cardona P,
    3. Arenillas JF, et al

    . Cerebrovascular events and outcomes in hospitalized patients with COVID-19: the SVIN COVID-19 Multinational Registry. Int J Stroke 2020 Sep 30. [Epub ahead of print] doi:10.1177/1747493020959216 pmid:32852257

    CrossRefPubMed
39. 39.
    1. Sugiyama Y,
    2. Tsuchiya T,
    3. Tanaka R, et al

    . Cerebral venous thrombosis in COVID-19-associated coagulopathy: a case report. J Clin Neurosci 2020;79:30–02 doi:10.1016/j.jocn.2020.07.038 pmid:33070913

    CrossRefPubMed
40. 40.
    1. Thompson A,
    2. Morgan C,
    3. Smith P, et al

    . Cerebral venous sinus thrombosis associated with COVID-19. Pract Neurol 2020 Oct 8. [Epub ahead of print] doi:10.1136/practneurol-2020-002678 pmid:33033161

    FREE Full Text
41. 41.
    1. Trimaille A,
    2. Curtiaud A,
    3. Marchandot B, et al

    . Venous thromboembolism in non-critically ill patients with COVID-19 infection. Thromb Res 2020;193:166–69 doi:10.1016/j.thromres.2020.07.033 pmid:32707275

    CrossRefPubMed
42. 42.
    1. Tu TM,
    2. Goh C,
    3. Tan YK, et al

    . Cerebral venous thrombosis in patients with COVID-19 infection: a case series and systematic review. J Stroke Cerebrovasc Dis 2020;29:105379 doi:10.1016/j.jstrokecerebrovasdis.2020.105379 pmid:33254369

    CrossRefPubMed
43. 43.↵
    1. Qureshi AI,
    2. Abd-Allah F,
    3. Alsenani F, et al

    . Management of acute ischemic stroke in patients with COVID-19 infection: report of an international panel. Int J Stroke 2020;15:540–54 doi:10.1177/1747493020923234] pmid:32362244

    CrossRefPubMed
44. 44.↵
    1. Wu Y,
    2. Xu X,
    3. Chen Z, et al

    . Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020;87:18–22 doi:10.1016/j.bbi.2020.03.031 pmid:32240762

    CrossRefPubMed
45. 45.↵
    1. Chen L,
    2. Li X,
    3. Chen M, et al

    . The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Cardiovasc Res 2020;116:1097–1100 doi:10.1093/cvr/cvaa078 pmid:32227090

    CrossRefPubMed
46. 46.↵
    1. Magro C,
    2. Mulvey JJ,
    3. Berlin D, et al

    . Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res 2020;220:1–13 doi:10.1016/j.trsl.2020.04.007 pmid:32299776

    CrossRefPubMed
47. 47.↵
    1. Noris M,
    2. Galbusera M,
    3. Gastoldi S, et al

    . Dynamics of complement activation in aHUS and how to monitor eculizumab therapy. Blood 2014;124:1715–26 doi:10.1182/blood-2014-02-558296 pmid:25037630

    Abstract/FREE Full Text
48. 48.↵
    1. Zhang Y,
    2. Xiao M,
    3. Zhang S, et al

    . Coagulopathy and antiphospholipid antibodies in patients with Covid-19. N Engl J Med 2020;382:e38 doi:10.1056/NEJMc2007575 pmid:32268022

    CrossRefPubMed